- Overcoming regulatory hurdles: How are agencies responding to new technologies?
- Ethical considerations: Ensuring patient data privacy and compliance.
- Operational barriers: Integration with existing trial frameworks (or do we need to adapt?)
- Future Outlook: What technologies will dominate in the next 5–10 years?
Chair: Joshua Cox, Vice President of Clinical Data & Analytics Capabilities, Eli Lilly and Company